Literature DB >> 7530924

Effect of aging on nitric oxide-mediated penile erection in rats.

H Garbán1, D Vernet, A Freedman, J Rajfer, N González-Cadavid.   

Abstract

Aging is an important risk factor for impotence in men. Because nitric oxide (NO) appears to be the mediator of corpora cavernosal smooth muscle relaxation, we have examined in 5-, 20-, and 30-mo-old rats, designated "adult," "old," and "senescent," respectively, whether aging causes a decrease of erectile response that may correlate with lower NO synthase (NOS) in the penis. Electric field stimulation (EFS) of the cavernosal nerve showed that the maximum intracavernosal pressure (MIP) declined in the old and senescent rats to 80 and 51% of the adult value, respectively. A low systemic dose of the NOS inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME; 2 mg/kg), reduced the MIP by only 38% in the adult rats but decreased it in the old and senescent rats by 72 and 80%, respectively. In the absence of EFS, intracavernosal papaverine (phosphodiesterase inhibitor), or nitroglycerin (NO donor), caused a lower erectile response in the old and senescent rats compared with the adult animals (MIP: 41 and 14%, respectively; duration of the erection 46 and 21%, respectively). Tissue sections from old and senescent penises showed increasing degrees of sclerotic degeneration. In comparison with the adult rats, the penile soluble NOS activity per gram of tissue that is sensitive to L-NAME decreased significantly by 63% in the senescent rats but was elevated in the old rats. These results indicate that aging causes an erectile failure due to factors initially independent from an impairment of penile NO synthesis but which are compounded in the very old rats by the decrease of penile NOS activity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7530924     DOI: 10.1152/ajpheart.1995.268.1.H467

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  16 in total

Review 1.  Therapy of erectile dysfunction: potential future treatments.

Authors:  Nestor F Gonzalez-Cadavid; Jacob Rajfer
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

Review 2.  Mesenchymal stem cell-based gene therapy for erectile dysfunction.

Authors:  J H Kim; H J Lee; Y S Song
Journal:  Int J Impot Res       Date:  2016-02-18       Impact factor: 2.896

3.  eNOS-uncoupling in age-related erectile dysfunction.

Authors:  J M Johnson; T J Bivalacqua; G A Lagoda; A L Burnett; B Musicki
Journal:  Int J Impot Res       Date:  2011-02-03       Impact factor: 2.896

4.  Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.

Authors:  H C Champion; T J Bivalacqua; A L Hyman; L J Ignarro; W J Hellstrom; P J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 5.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

Review 6.  Gene therapy as future treatment of erectile dysfunction.

Authors:  Naoki Yoshimura; Ryuichi Kato; Michael B Chancellor; Joel B Nelson; Joseph C Glorioso
Journal:  Expert Opin Biol Ther       Date:  2010-09       Impact factor: 4.388

7.  Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat.

Authors:  Monica G Ferrini; Su M Hlaing; Andre Chan; Jorge N Artaza
Journal:  Andrology (Los Angel)       Date:  2015-05-25

8.  Apoptosis of corpus cavernosum in patients with organic erectile dysfunction.

Authors:  Fatih Tarhan; Gülderen Yanikkaya Demirel; Uğur Kuyumcuoğlu; Gökhan Faydaci; Bilal Eryildirim
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226

9.  Soluble Guanylate Cyclase Stimulators and Activators.

Authors:  Peter Sandner; Daniel P Zimmer; G Todd Milne; Markus Follmann; Adrian Hobbs; Johannes-Peter Stasch
Journal:  Handb Exp Pharmacol       Date:  2021

10.  Activation and potentiation of the NO/cGMP pathway by NG-hydroxyl-L-arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageing.

Authors:  Javier Angulo; Pedro Cuevas; Argentina Fernández; Sonia Gabancho; Antonio Allona; Antonio Martín-Morales; Ignacio Moncada; Iñigo Sáenz de Tejada
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.